Winter & Associates’s HCA Healthcare HCA Stock Holding History

Winter & Associates’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-465	Closed	-$225K	–	91
2026 Q1	$225K	Hold	465	–	–	0.2%	77
2025 Q4	$217K	Buy	+465	New	+$216K	0.2%	78

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Winter & Associates's HCA Position: Q2 2026 in Review

Winter & Associates sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 465 shares — an estimated $225K sold.

Winter & Associates first reported a position in HCA in Q4 2025 and held it in 2 quarters. The position peaked at $225K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Winter & Associates reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
Winter & Associates sold 465 HCA Healthcare shares in Q2 2026, an estimated $225K.
Winter & Associates first reported a position in HCA Healthcare in Q4 2025 and held it in 2 quarters.
Winter & Associates's HCA Healthcare position peaked at $225K in Q1 2026.
1,336 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Winter & Associates's 13F filing for Q2 2026, filed 9 Jul 2026.